Comparison of lansoprazole‐based triple and dual therapy for treatment of Helicobacter pylori‐related duodenal ulcer: an Asian multicentre double‐blind randomized placebo controlled study

: In Asian countries with limited resources, clarithromycin‐based triple therapy may not be readily available. There are also few direct comparisons of different regimens in Asia.

[1]  A. Mainous,et al.  Practice Patterns for Peptic Ulcer Disease: Are Family Physicians Testing for H. pylori? , 1999, Helicobacter.

[2]  Lau,et al.  Triple therapy for Helicobacter pylori eradication is more effective than long‐term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long‐term follow‐up study , 1999, Alimentary pharmacology & therapeutics.

[3]  A. Terano,et al.  [Asia Pacific Consensus Conference on the management of Helicobacter pylori]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[4]  K. Chu,et al.  A prospective randomized trial comparing the use of omeprazole-based dual and triple therapy for eradication of helicobacter pylori , 1998, American Journal of Gastroenterology.

[5]  Y. Habu,et al.  Triple Therapy with Omeprazole, Amoxicillin and Clarithromycin Is Effective against Helicobacter Pylori Infection in Gastric Ulcer Patients as well as in Duodenal Ulcer Patients , 1998, Digestion.

[6]  S. Lam,et al.  Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection , 1998, Journal of gastroenterology and hepatology.

[7]  C. O'Morain,et al.  One week triple therapy for Helicobacter pylori: a multicentre comparative study , 1997, Gut.

[8]  N. Parasakthi,et al.  Comparison of two 1‐week low‐dose omeprazole triple therapies— optimal treatment for Helicobacter pylori infection? , 1997, Alimentary pharmacology & therapeutics.

[9]  B. C. Wong,et al.  Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study. , 1997, Gut.

[10]  A. V. van Zwet,et al.  One‐week triple therapy with omeprazole, amoxycillin and tinidazole for Helicobacter pylori infection: the significance of imidazole resistance , 1997, Alimentary pharmacology & therapeutics.

[11]  B. Moum,et al.  Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? , 1997, The American journal of gastroenterology.

[12]  A. Weissfeld,et al.  Double‐Blind, Multicenter Evaluation of Lansoprazole and Amoxicillin Dual Therapy for the Cure of Helicobacter pylori Infection , 1996, Helicobacter.

[13]  M. Walker,et al.  Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection , 1996, Alimentary pharmacology & therapeutics.

[14]  R. Spiller,et al.  Eradication of Helicobacter pylori Using One‐week Triple Therapies Combining Omeprazole with Two Antimicrobials: The MACH I Study , 1996, Helicobacter.

[15]  B. C. Wong,et al.  Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. , 1996, Gut.

[16]  D. Graham,et al.  Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. , 1995, The American journal of gastroenterology.

[17]  S. Massarrat,et al.  Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. , 1995, The American journal of gastroenterology.

[18]  S. Lam,et al.  Prevalence of metronidazole resistant Helicobacter pylori (Hp) strains among the Chinese peptic ulcer disease patients and normals in Hong Kong , 1995 .

[19]  D. Graham,et al.  Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin. , 1995, The American journal of gastroenterology.

[20]  C. O'Morain,et al.  Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori , 1994, Antimicrobial Agents and Chemotherapy.

[21]  S. W. Hosking,et al.  Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial , 1994, The Lancet.

[22]  A. Bowden,et al.  Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens. , 1993, The Quarterly journal of medicine.

[23]  J. Thijs,et al.  Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori. , 1993, Scandinavian journal of gastroenterology.

[24]  D. Graham,et al.  Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial. , 1991, Annals of Internal Medicine.

[25]  S. Massarrat,et al.  Factors affecting the healing rate of duodenal and pyloric ulcers with low-dose antacid treatment. , 1981, Gut.